These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39309439)

  • 1. Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer.
    Li B; Cheng B; Huang H; Huang S; Yu S; Li Z; Peng S; Du T; Xie R; Huang H
    Int J Biol Sci; 2024; 20(12):4635-4653. PubMed ID: 39309439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201).
    Borgmann H; Lallous N; Ozistanbullu D; Beraldi E; Paul N; Dalal K; Fazli L; Haferkamp A; Lejeune P; Cherkasov A; Gleave ME
    Eur Urol; 2018 Jan; 73(1):4-8. PubMed ID: 28851578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FASN contributes to ADM resistance of diffuse large B-cell lymphoma by inhibiting ferroptosis via nf-κB/STAT3/GPX4 axis.
    Zhong X; Zhang W; Zhang W; Yu N; Li W; Song X
    Cancer Biol Ther; 2024 Dec; 25(1):2403197. PubMed ID: 39345091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network.
    Sun Y; Guo W; Guo Y; Lin Z; Wang D; Guo Q; Zhou Y
    Food Chem Toxicol; 2022 Nov; 169():113450. PubMed ID: 36208653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
    Baumgart SJ; Nevedomskaya E; Lesche R; Newman R; Mumberg D; Haendler B
    Mol Oncol; 2020 Sep; 14(9):2022-2039. PubMed ID: 32333502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
    Wen S; Niu Y; Lee SO; Yeh S; Shang Z; Gao H; Li Y; Chou F; Chang C
    Mol Carcinog; 2016 Dec; 55(12):2278-2290. PubMed ID: 26894509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR.
    Hsieh PF; Jiang WP; Basavaraj P; Huang SY; Ruangsai P; Wu JB; Huang GJ; Huang WC
    Phytomedicine; 2021 Dec; 93():153806. PubMed ID: 34740154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.
    Sugawara T; Baumgart SJ; Nevedomskaya E; Reichert K; Steuber H; Lejeune P; Mumberg D; Haendler B
    Int J Cancer; 2019 Sep; 145(5):1382-1394. PubMed ID: 30828788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.
    Buck SAJ; Van Hemelryk A; de Ridder C; Stuurman D; Erkens-Schulze S; van 't Geloof S; Teubel WJ; Koolen SLW; Martens-Uzunova ES; van Royen ME; de Wit R; Mathijssen RHJ; van Weerden WM
    Mol Cancer Ther; 2024 May; 23(5):711-720. PubMed ID: 38030379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
    Nakayama H; Sekine Y; Oka D; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Suzuki K
    Prostate; 2022 Feb; 82(3):314-322. PubMed ID: 34843630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer.
    Jin Y; Chen Z; Dong J; Wang B; Fan S; Yang X; Cui M
    FEBS Open Bio; 2021 May; 11(5):1343-1352. PubMed ID: 33665967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Darolutamide does not interfere with OATP-mediated uptake of docetaxel.
    Buck SAJ; Talebi Z; Drabison T; Jin Y; Gibson AA; Hu P; de Bruijn P; de Ridder CMA; Stuurman D; Hu S; van Weerden WM; Koolen SLW; de Wit R; Sparreboom A; Mathijssen RHJ; Eisenmann ED
    Int J Cancer; 2024 Jul; 155(2):314-323. PubMed ID: 38491867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
    Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
    Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer.
    Zheng YN; Lou SY; Lu J; Zheng FL; Tang YM; Zhang EJ; Cui SL; Zhao HJ
    Cell Death Dis; 2024 Jul; 15(7):474. PubMed ID: 38956060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
    Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
    Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
    Kanagasabai T; Li G; Shen TH; Gladoun N; Castillo-Martin M; Celada SI; Xie Y; Brown LK; Mark ZA; Ochieng J; Ballard BR; Cordon-Cardo C; Adunyah SE; Jin R; Matusik RJ; Chen Z
    Cancer Lett; 2022 Jan; 525():46-54. PubMed ID: 34610416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
    Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
    PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    Huang LH; Chung HY; Su HM
    BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis.
    Fan A; Li Y; Zhang Y; Meng W; Pan W; Chen M; Ma Z; Chen W
    Apoptosis; 2024 Oct; 29(9-10):1679-1695. PubMed ID: 38478171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.